Suzana Assad Kahn

3PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 21, 2026
Targeting CD24 activates macrophages to reduce tumor burden in preclinical models of solid tumors.

|Sep 22, 2017
Patient-derived osteosarcoma cells are resistant to methotrexate.

Amanda Dos Santos Cavalcanti, Walter Meohas, Gabriele de Oliveira Ribeiro

|Mar 17, 2017
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.

Sharareh Gholamin, Siddhartha S Mitra, Abdullah H Feroze

Pageof 1